Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
211M
-
Number of holders
-
97
-
Total 13F shares, excl. options
-
57M
-
Shares change
-
+3.75M
-
Total reported value, excl. options
-
$998M
-
Value change
-
+$70M
-
Put/Call ratio
-
5.54
-
Number of buys
-
46
-
Number of sells
-
-45
-
Price
-
$17.51
Significant Holders of INSMED Inc - Common Stock, par value $0.01 per share (INSM) as of Q1 2017
123 filings reported holding INSM - INSMED Inc - Common Stock, par value $0.01 per share as of Q1 2017.
INSMED Inc - Common Stock, par value $0.01 per share (INSM) has 97 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 57M shares
of 211M outstanding shares and own 27.03% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (10.8M shares), FMR LLC (9.3M shares), Palo Alto Investors, LLC (5.53M shares), ORBIMED ADVISORS LLC (4.81M shares), BlackRock Inc. (4.68M shares), VANGUARD GROUP INC (3.78M shares), JANUS CAPITAL MANAGEMENT LLC (2.81M shares), STATE STREET CORP (1.5M shares), JPMORGAN CHASE & CO (1.47M shares), and JENNISON ASSOCIATES LLC (1.17M shares).
This table shows the top 97 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.